Loading…

Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability

Approximately 60% of outpatients with advanced cancer experience pain; therefore, self-management of opioid use is important for appropriate pain relief. To date, no studies have clearly described the concept of opioid self-management or assessed the factors involved, including the improvement of se...

Full description

Saved in:
Bibliographic Details
Published in:BMC palliative care 2022-06, Vol.21 (1), p.102-102, Article 102
Main Authors: Yoshida, Shiori, Sato, Fumiko, Tagami, Keita, Sasaki, Rie, Takahashi, Chikako, Sasaki, Konosuke, Takahashi, Shin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Approximately 60% of outpatients with advanced cancer experience pain; therefore, self-management of opioid use is important for appropriate pain relief. To date, no studies have clearly described the concept of opioid self-management or assessed the factors involved, including the improvement of self-management abilities. This study developed, and evaluated the validity and reliability of an opioid self-management scale for advanced cancer patients with pain (OSSA). Opioid self-management in advanced cancer patients with pain was defined as the management of opioid medication performed by patients with advanced cancer to relieve cancer pain on their own. Three phases were required for validation and reliability of the OSSA: 1) testing content validity, 2) testing face validity, and 3) testing construct validity, concurrent validity and reliability. After a three-phase process, the OSSA consisted of 33 items on six subscales. The structural equation modeling was such that the χ value was 709.8 (p 
ISSN:1472-684X
1472-684X
DOI:10.1186/s12904-022-00987-4